PARE0007 HOPES AND FEARS OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS IN SPAIN. THE VALUE OF PATIENT OPINION: RESULTS FROM THE SPANISH ATLAS
M. Garrido-Cumbrera 1,2 , P. The following stand out among drug treatment-related concerns: having more effective treatments (32%), sustaining the results of biologic therapies (29%), being able to start on biologics (8%), the public health system funding non-drug treatments for AS (8%), eliminating secondary effects (15%), reducing prices (4%), and correct use (4%).
With respect to their fears, patients stated that their main concern was mobility loss (31%), followed by loss of independence (23%), disability (22%), stiffness (12%), structural damage (3%), organ damage (3%), other illnesses and diseases related (3%), physical decline (3%), and sight loss (1%). Patients who expressed fear regarding their disease listed their greatest concern was that they would not overcome or tolerate pain (56%), followed by the fear that the disease would develop (32%), along with apprehension about flare-ups (7%), and tiredness (5%). With respect to patients' personal objectives in terms of their treatments, they highlighted the wish that their treatment would, first, help them to reduce and eliminate pain, increasing their in mobility, improved quality of life, the avoidance of structural damage and the disease eventually being cured. Conclusions: Analysis of patient opinion using qualitative information has enabled the identification of important concerns for patients such as discovering the cause of the disease, reducing pain and structural damage, loss of self-sufficiency and disability. Background: Transition is a multifaceted process involving medical, psychosocial, educational needs of the teenager who must move from a pediatric care to adult care system. The pediatric paradigm focuses on the family, it focuses on aspects of growth and development, often neglecting, to acknowledge the increasing independence and autonomy of the patient as an individual. The culture of adult medicine implies to have as a partner a patient independent and autonomous in the management of the disease, including aspects of playing, ignoring the issues related to the growth, development and relations with the family. Objectives: to drive the patient along the transition, getting him finding the new treating as a continued assistance, more mature and personalized in sharing issues related to the disease; to create a best practice of transition service. Methods: promoted by AMaR Piemonte -regional expression of ANMAR -and thanks to the availability and sensitivity of the doctors of the Pediatric Rheumatology Service (responsible Prof. Silvana Martino) and the UOA Rheumatology (director dr. Enrico Fusaro), located in two different buildings of the same "Città della Salute e della Scienza di Torino" hospital, it was possible to organize a transition pathway for teenagers since eighteen, structured as follows:
• first telephone contact between Pediatrician Rheumatologist and Rheumatologist • sharing of clinical and personal information about the young patient • introduction to the new care giver: during the routine consultation Pediatrician Rheumatologist presents his colleague, anticipating the different types of examinations and departmental activities and highlighting the peculiarities and sensitivity of his colleague • meeting with parents: on the fringes the two specialists meet parents, preparing them for their future role and announcing that in the next visit they will be excluded • transition examination: directly scheduled, it is a joint examination by the two rheumatologists to the young patient, who is directly involved discussing his health state and the decisions to be taken to continue therapies or monitoring the disease (if in remission). A second one may be scheduled if the young patient shows severe psychological problems. A collegial meeting between patient, rheumatologists and physiatrist/rehabilitator will be programmed if a special rehabilitation is needed • taking care: the new rheumatologist takes care of the young patient All the pathway takes end in a period of time not exceeding one month, with a maximum of three consultations. Results: 52 patients (79% female, 21% male) taken in care by "adult" rheumatology since 2012 to 2016. No patient reports he lived the transition as a trauma and 10%, even saying to have found in the new rheumatologist a sure and affordable referral, stay in contact with the pediatric rheumatologist "because of emotional issues". 58% remains under treatment with DMARDs and biologics; in 32% of patients an extra-articular manifestation occurs even in the absence of clinical parameters indicative of medium-high disease activity. The remaining 10%, in remission, continues the control. Conclusions: Transition is an educational and therapeutic process, not an event; it requires collaboration between the teenager, family and caregivers. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.3111
